These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3835819)

  • 1. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E; Kremmer T; Boldizsár M
    Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
    Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
    Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture.
    Ban J; Olah E; Werber G
    Cancer Treat Rep; 1982 Feb; 66(2):343-9. PubMed ID: 6895716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and cell kinetic effects of 3,4,5-trihydroxybenzohydroxamic acid (VF 122) in hepatoma 3924A cells.
    Ban J; Olah E; Weber G
    Cancer Treat Rep; 1982 Dec; 66(12):2071-80. PubMed ID: 7139648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS; Lui MS; Weber G
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
    Natsumeda Y; Yamada Y; Yamaji Y; Weber G
    Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
    Ban J; Weber G
    Biochem Biophys Res Commun; 1992 Apr; 184(2):551-9. PubMed ID: 1349474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN
    Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin.
    Weber G; Lui MS; Jayaram HN; Pillwein K; Natsumeda Y; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1985; 23():81-99. PubMed ID: 3907307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiazofurin-induced selective depression of NAD content in hepatoma 3924A.
    Liepnieks JJ; Faderan MA; Lui MS; Weber G
    Biochem Biophys Res Commun; 1984 Jul; 122(1):345-9. PubMed ID: 6743337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.